Literature DB >> 24485137

Emerging medical devices for minimally invasive cell therapy.

Eoin D O'Cearbhaill1, Kelvin S Ng2, Jeffrey M Karp3.   

Abstract

The past decade has seen the first wave of cell-based therapeutics undergo clinical trials with varying degrees of success. Although attention is increasingly focused on clinical trial design, owing to spiraling regulatory costs, tools used in delivering cells and sustaining the cells' viability and functions in vivo warrant careful scrutiny. While the clinical administration of cell-based therapeutics often requires additional safeguarding and targeted delivery compared with traditional therapeutics, there is significant opportunity for minimally invasive device-assisted cell therapy to provide the physician with new regenerative options at the point of care. Herein we detail exciting recent advances in medical devices that will aid in the safe and efficacious delivery of cell-based therapeutics.
Copyright © 2014 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.

Keywords:  FDA; Induced Pluripotent Stem Cell; MSC; Mesenchymal Stem Cell; POZNAN; PTFE; Percutaneous Transvenous Transplantation of Autologous Myoblasts in the Treatment of Postinfarction Heart Failure; T1D; TOPCARE-AMI; Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction; U.S. Food and Drug Administration; iPSC; polytetrafluoroethylene; type 1 diabetes

Mesh:

Year:  2014        PMID: 24485137     DOI: 10.1016/j.mayocp.2013.10.020

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  15 in total

Review 1.  Multiscale technologies for treatment of ischemic cardiomyopathy.

Authors:  Morteza Mahmoudi; Mikyung Yu; Vahid Serpooshan; Joseph C Wu; Robert Langer; Richard T Lee; Jeffrey M Karp; Omid C Farokhzad
Journal:  Nat Nanotechnol       Date:  2017-09-06       Impact factor: 39.213

Review 2.  Ventricular wall biomaterial injection therapy after myocardial infarction: Advances in material design, mechanistic insight and early clinical experiences.

Authors:  Yang Zhu; Yasumoto Matsumura; William R Wagner
Journal:  Biomaterials       Date:  2017-03-01       Impact factor: 12.479

Review 3.  On the Road to Regeneration: "Tools" and "Routes" Towards Efficient Cardiac Cell Therapy for Ischemic Cardiomyopathy.

Authors:  Francesca Pagano; Vittorio Picchio; Isotta Chimenti; Alessia Sordano; Elena De Falco; Mariangela Peruzzi; Fabio Miraldi; Elena Cavarretta; Giuseppe Biondi Zoccai; Sebastiano Sciarretta; Giacomo Frati; Antonino G M Marullo
Journal:  Curr Cardiol Rep       Date:  2019-10-31       Impact factor: 2.931

4.  Biofabrication of injectable fibrin microtissues for minimally-invasive therapies: application of surfactants.

Authors:  Ramkumar T Annamalai; Tapan Naik; Haley Prout; Andrew J Putnam; Jan P Stegemann
Journal:  Biomed Mater       Date:  2018-04-16       Impact factor: 3.715

Review 5.  Adult Mesenchymal Stem Cells: When, Where, and How.

Authors:  Arnold I Caplan
Journal:  Stem Cells Int       Date:  2015-07-26       Impact factor: 5.443

Review 6.  Preconditioning stem cells for in vivo delivery.

Authors:  Sébastien Sart; Teng Ma; Yan Li
Journal:  Biores Open Access       Date:  2014-08-01

7.  Matrix-Assisted Transplantation of Functional Beige Adipose Tissue.

Authors:  Kevin M Tharp; Amit K Jha; Judith Kraiczy; Alexandra Yesian; Grigory Karateev; Riccardo Sinisi; Elena A Dubikovskaya; Kevin E Healy; Andreas Stahl
Journal:  Diabetes       Date:  2015-08-20       Impact factor: 9.461

8.  A direct tissue-grafting approach to increasing endogenous brown fat.

Authors:  Nicole R Blumenfeld; Hwan June Kang; Anna Fenzl; Ziwei Song; Janice J Chung; Ranjodh Singh; Roshawn Johnson; Ayse Karakecili; Jun B Feranil; Ninna S Rossen; Vivian Zhang; Sahir Jaggi; Bret McCarty; Steven Bessler; Gary J Schwartz; Robert Grant; Judith Korner; Florian W Kiefer; Brian M Gillette; Samuel K Sia
Journal:  Sci Rep       Date:  2018-05-21       Impact factor: 4.379

9.  Novel Techniques to Improve Precise Cell Injection.

Authors:  Walter Linzenbold; Andreas Fech; Manuela Hofmann; Wilhelm K Aicher; Markus D Enderle
Journal:  Int J Mol Sci       Date:  2021-06-14       Impact factor: 5.923

Review 10.  Approaches in Immunotherapy, Regenerative Medicine, and Bioengineering for Type 1 Diabetes.

Authors:  Christopher Kopan; Tori Tucker; Michael Alexander; M Rezaa Mohammadi; Egest J Pone; Jonathan Robert Todd Lakey
Journal:  Front Immunol       Date:  2018-06-12       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.